Research progress on post-translational modification of proteins and cardiovascular diseases

被引:15
作者
Cheng, XueLi [1 ,2 ]
Wang, Kai [2 ]
Zhao, Yan [2 ]
Wang, Kun [1 ,2 ]
机构
[1] Qingdao Univ, Shandong Prov Maternal & Child Hlth Care Hosp, Key Lab Birth Regulat & Control Technol Natl Hlth, Jinan 250014, Shandong, Peoples R China
[2] Qingdao Univ, Affiliated Hosp, Inst Translat Med, Qingdao 266073, Shandong, Peoples R China
基金
中国国家自然科学基金;
关键词
INDUCED CARDIAC-HYPERTROPHY; OXIDATIVE STRESS; HEART-FAILURE; ACTIVATION; INJURY; METHYLATION; SUMOYLATION; EXPRESSION; PROTECTS; PATHWAY;
D O I
10.1038/s41420-023-01560-5
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Cardiovascular diseases (CVDs) such as atherosclerosis, myocardial remodeling, myocardial ischemia-reperfusion (I/R) injury, heart failure, and oxidative stress are among the greatest threats to human health worldwide. Cardiovascular pathogenesis has been studied for decades, and the influence of epigenetic changes on CVDs has been extensively studied. Post-translational modifications (PTMs), including phosphorylation, glycosylation, methylation, acetylation, ubiquitination, ubiquitin-like and nitrification, play important roles in the normal functioning of the cardiovascular system. Over the past decade, with the application of high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS), an increasing number novel acylation modifications have been discovered, including propionylation, crotonylation, butyrylation, succinylation, lactylation, and isonicotinylation. Each change in protein conformation has the potential to alter protein function and lead to CVDs, and this process is usually reversible. This article summarizes the mechanisms underlying several common PTMs involved in the occurrence and development of CVDs.
引用
收藏
页数:12
相关论文
共 118 条
  • [1] Simvastatin prevents isoproterenol-induced cardiac hypertrophy through modulation of the JAK/STAT pathway
    Al-Rasheed, Nouf M.
    Al-Oteibi, Maha M.
    Al-Manee, Reem Z.
    Al-Shareef, Sarah A.
    Al-Rasheed, Nawal M.
    Hasan, Iman H.
    Mohamad, Raeesa A.
    Mahmoud, Ayman M.
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2015, 9 : 3217 - 3229
  • [2] Molecular nature and physiological role of the mitochondrial calcium uniporter channel
    Alevriadou, B. Rita
    Patel, Akshar
    Noble, Megan
    Ghosh, Sagnika
    Gohil, Vishal M.
    Stathopulos, Peter B.
    Madesh, Muniswamy
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2020, 320 (04): : C465 - C482
  • [3] Lactate induces tumour necrosis factor-α, interleukin-6 and interleukin-1β release in microglial- and astroglial-enriched primary cultures
    Andersson, AK
    Rönnbäck, L
    Hansson, E
    [J]. JOURNAL OF NEUROCHEMISTRY, 2005, 93 (05) : 1327 - 1333
  • [4] Activation of liver X receptor attenuates lysophosphatidylcholine-induced IL-8 expression in endothelial cells via the NF-κB pathway and SUMOylation
    Bi, Xukun
    Song, Jiale
    Gao, Jing
    Zhao, Juanjuan
    Wang, Meihui
    Scipione, Corey A.
    Koschinsky, Marlys L.
    Wang, Zhao V.
    Xu, Shiming
    Fu, Guosheng
    [J]. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2016, 20 (12) : 2249 - 2258
  • [5] Pak2 Regulation of Nrf2 Serves as a Novel Signaling Nexus Linking ER Stress Response and Oxidative Stress in the Heart
    Binder, Pablo
    Nguyen, Binh
    Collins, Lucy
    Zi, Min
    Liu, Wei
    Christou, Foteini
    Luo, Xiaojing
    Hille, Susanne S.
    Frey, Norbert
    Cartwright, Elizabeth J.
    Chernoff, Jonathan
    Mueller, Oliver J.
    Guan, Kaomei
    Wang, Xin
    [J]. FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [6] Arginine Methylation: The Coming of Age
    Blanc, Romeo S.
    Richard, Stephane
    [J]. MOLECULAR CELL, 2017, 65 (01) : 8 - 24
  • [7] Protein kinase CK2: a potential therapeutic target for diverse human diseases
    Borgo, Christian
    D'Amore, Claudio
    Sarno, Stefania
    Salvi, Mauro
    Ruzzene, Maria
    [J]. SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2021, 6 (01)
  • [8] Characterization of the cardiac succinylome and its role in ischemia-reperfusion injury
    Boylston, Jennifer A.
    Sun, Junhui
    Chen, Yong
    Gucek, Marjan
    Sack, Michael N.
    Murphy, Elizabeth
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2015, 88 : 73 - 81
  • [9] Chronically Elevating Circulating Ketones Can Reduce Cardiac Inflammation and Blunt the Development of Heart Failure
    Byrne, Nikole J.
    Soni, Shubham
    Takahara, Shingo
    Ferdaoussi, Mourad
    Al Batran, Rami
    Darwesh, Ahmed M.
    Levasseur, Jody L.
    Beker, Donna
    Vos, Dyonne Y.
    Schmidt, Mya A.
    Alam, Abrar S.
    Maayah, Zaid H.
    Schertzer, Jonathan D.
    Seubert, John M.
    Ussher, John R.
    Dyck, Jason R. B.
    [J]. CIRCULATION-HEART FAILURE, 2020, 13 (06)
  • [10] Low Serum Ferroxidase I Activity Is Associated With Mortality in Heart Failure and Related to Both Peroxynitrite-Induced Cysteine Oxidation and Tyrosine Nitration of Ceruloplasmin
    Cabassi, Aderville
    Binno, Simone Maurizio
    Tedeschi, Stefano
    Ruzicka, Valerie
    Dancelli, Simona
    Rocco, Rossana
    Vicini, Vanni
    Coghi, Pietro
    Regolisti, Giuseppe
    Montanari, Alberto
    Fiaccadori, Enrico
    Govoni, Paolo
    Piepoli, Massimo
    de Champlain, Jacques
    [J]. CIRCULATION RESEARCH, 2014, 114 (11) : 1723 - +